Intrommune Therapeutics, Inc. is looking to raise $10,000
Apr 12, 2018•over 7 years ago
Target Amount
$10,000
Deadline
Jun 17, 2018
CIK0001736977
File Number007-00035
Issuer Information
Issuer
Intrommune Therapeutics, Inc.
Location
20 w 125th st. unit #1
new york, new york, united states
About
Intrommune Therapeutics is a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies.
